Amalgamated Bank’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.48M Sell
44,353
-2,183
-5% -$226K 0.03% 489
2026
Q1
$4.5M Buy
46,536
+1,942
+4% +$199K 0.03% 458
2025
Q4
$4.73M Sell
44,594
-2,144
-5% -$249K 0.03% 439
2025
Q3
$5.94M Sell
46,738
-48
-0.1% -$5.71K 0.04% 343
2025
Q2
$5.74M Buy
46,786
+671
+1% +$76.6K 0.04% 332
2025
Q1
$4.67M Sell
46,115
-2,011
-4% -$196K 0.04% 389
2024
Q4
$4.44M Buy
48,126
+239
+0.5% +$23.5K 0.04% 434
2024
Q3
$4.63M Sell
47,887
-12,904
-21% -$1.16M 0.04% 419
2024
Q2
$5.21M Sell
60,791
-4,108
-6% -$345K 0.04% 391
2024
Q1
$5.36M Sell
64,899
-410
-0.6% -$30K 0.05% 423
2023
Q4
$4.36M Sell
65,309
-7,754
-11% -$502K 0.03% 554
2023
Q3
$4.91M Buy
73,063
+7,276
+11% +$500K 0.04% 449
2023
Q2
$4.45M Sell
65,787
-2,562
-4% -$161K 0.04% 498
2023
Q1
$3.7M Sell
68,349
-18,364
-21% -$1.07M 0.03% 588
2022
Q4
$5.19M Buy
86,713
+15,571
+22% +$847K 0.05% 450
2022
Q3
$3.22M Sell
71,142
-18,497
-21% -$925K 0.03% 612
2022
Q2
$4M Sell
89,639
-556
-0.6% -$28.5K 0.04% 534
2022
Q1
$5.1M Sell
90,195
-1,217
-1% -$63.5K 0.04% 475
2021
Q4
$4.75M Buy
91,412
+188
+0.2% +$9.7K 0.04% 547
2021
Q3
$5.45M Sell
91,224
-9,327
-9% -$587K 0.05% 448
2021
Q2
$6.24M Buy
100,551
+81,194
+419% +$5.41M 0.05% 417
2021
Q1
$1.26M Sell
19,357
-1,482
-7% -$96.7K 0.05% 427
2020
Q4
$1.37M Buy
20,839
+61
+0.3% +$3.59K 0.05% 380
2020
Q3
$1.07M Sell
20,778
-162
-0.8% -$8.31K 0.05% 415
2020
Q2
$1.03M Sell
20,940
-9,791
-32% -$528K 0.05% 409
2020
Q1
$1.56M Sell
30,731
-836
-3% -$48.2K 0.04% 446
2019
Q4
$1.74M Buy
31,567
+2,559
+9% +$139K 0.03% 569
2019
Q3
$1.46M Buy
29,008
+1,872
+7% +$94K 0.03% 587
2019
Q2
$1.37M Sell
27,136
-1,995
-7% -$96.8K 0.03% 618
2019
Q1
$1.35M Buy
29,131
+404
+1% +$20.5K 0.03% 582
2018
Q4
$1.41M Buy
28,727
+10,625
+59% +$604K 0.04% 479
2018
Q3
$1.12M Sell
18,102
-11,920
-40% -$725K 0.03% 620
2018
Q2
$1.62M Buy
30,022
+12,213
+69% +$610K 0.04% 498
2018
Q1
$810K Sell
17,809
-289
-2% -$12.4K 0.02% 771
2017
Q4
$711K Buy
18,098
+1,078
+6% +$41K 0.02% 832
2017
Q3
$628K Buy
17,020
+871
+5% +$31K 0.02% 849
2017
Q2
$622K Buy
16,149
+805
+5% +$29.5K 0.02% 855
2017
Q1
$523K Sell
15,344
-12
-0.1% -$394 0.03% 813
2016
Q4
$504K Buy
15,356
+3,558
+30% +$115K 0.02% 824
2016
Q3
$381K Buy
11,798
+15
+0.1% +$486 0.02% 869
2016
Q2
$390K Sell
11,783
-332
-3% -$10.4K 0.02% 853
2016
Q1
$363K Buy
12,115
+1,063
+10% +$29.4K 0.04% 746
2015
Q4
$306K Sell
11,052
-1,000
-8% -$28.4K 0.04% 771
2015
Q3
$368K Buy
12,052
+153
+1% +$5.33K 0.04% 733
2015
Q2
$436K Buy
11,899
+2,898
+32% +$103K 0.04% 660
2015
Q1
$318K Buy
9,001
+426
+5% +$14.6K 0.04% 650
2014
Q4
$262K Buy
8,575
+36
+0.4% +$1.12K 0.04% 660
2014
Q3
$251K Buy
8,539
+9
+0.1% +$274 0.04% 678
2014
Q2
$243K Sell
8,530
-1,141
-12% -$31.8K 0.04% 719
2014
Q1
$276K Sell
9,671
-96
-1% -$2.5K 0.05% 599
2013
Q4
$259K Buy
+9,767
New +$272K 0.04% 641

Other funds holding EHC

Amalgamated Bank's EHC Position: Q2 2026 in Review

Amalgamated Bank reduced its Encompass Health (EHC) stake by 4.7% in Q2 2026, selling an estimated $226K and leaving 44,353 shares worth $4.48M. The position accounts for 0.03% of the portfolio, ranked #489.

Amalgamated Bank first reported a position in EHC in Q4 2013 and has held it in 51 quarters since. The position peaked at $6.24M in Q2 2021. 274 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Amalgamated Bank held 44,353 shares of Encompass Health worth $4.48M as of Q2 2026.
  • Amalgamated Bank sold 2,183 Encompass Health shares in Q2 2026, an estimated $226K.
  • Encompass Health made up 0.03% of Amalgamated Bank's portfolio in Q2 2026, its #489 holding.
  • Amalgamated Bank first reported a position in Encompass Health in Q4 2013 and has held it in 51 quarters since.
  • Amalgamated Bank's Encompass Health position peaked at $6.24M in Q2 2021.
  • 274 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Amalgamated Bank's 13F filing for Q2 2026, filed 23 Jul 2026.